Anaheim, CA10 Active Studies

Atopic Dermatitis Clinical Trials in Anaheim, CA

Find 10 actively recruiting atopic dermatitis clinical trials in Anaheim, CA. Connect with local research sites and explore new treatment options.

10
Active Trials
8
Sponsors
5,757
Enrolling

Recruiting Atopic Dermatitis Studies in Anaheim

RecruitingAnaheim, CANCT05050162

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

This phase II/III trial compares whether cisplatin given weekly with radiation therapy is better tolerated than cisplatin given every three weeks with radiation therapy for the treatment of head and n...

1,714 participants
NRG Oncology
View Study Details
RecruitingAnaheim, CANCT05492578

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

This is an open-label, Phase 2/Phase 3, long-term extension study for treatment of participants of previous amlitelimab clinical trials in moderate to severe atopic dermatitis. The purpose of this st...

1,551 participants
Sanofi
View Study Details
RecruitingAnaheim, CANCT02339571

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melan...

600 participants
National Cancer Institute (NCI)
View Study Details
RecruitingAnaheim, CANCT06799000

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis sup...

555 participants
Novartis Pharmaceuticals
View Study Details
RecruitingAnaheim, CANCT04879329

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

This study is being done to see if a drug called disitamab vedotin, alone or with pembrolizumab, works to treat HER2 expressing urothelial cancer. It will also test how safe the drug is for participan...

372 participants
Seagen, a wholly owned subsidiary of Pfizer
View Study Details
RecruitingAnaheim, CANCT04781140

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD....

286 participants
Supernus Pharmaceuticals, Inc.
View Study Details
RecruitingAnaheim, CANCT04671667

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with...

188 participants
National Cancer Institute (NCI)
View Study Details
RecruitingAnaheim, CANCT06431256

Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD

This study will evaluate the efficacy, safety and pharmacokinetics of HLD200 (20 mg and 40 mg) in children aged 4 to 5 years with ADHD....

168 participants
Ironshore Pharmaceuticals and Development, Inc
View Study Details
RecruitingAnaheim, CANCT03180268

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by sur...

163 participants
NRG Oncology
View Study Details
RecruitingAnaheim, CANCT06215144

Study to Evaluate NRCT-101SR in Pediatric Subjects with ADHD

To evaluate the efficacy and safety of NRCT-101SR compared to placebo in subjects 13-17 years of age with ADHD...

160 participants
Neurocentria, Inc.
View Study Details

About Atopic Dermatitis Clinical Trials in Anaheim

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 10 atopic dermatitis clinical trials recruiting participants in Anaheim, CA. These studies are seeking a combined 5,757 participants. Research is being sponsored by NRG Oncology, Sanofi, National Cancer Institute (NCI) and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Anaheim — FAQ

Are there atopic dermatitis clinical trials in Anaheim?

Yes, there are 10 atopic dermatitis clinical trials currently recruiting in Anaheim, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Anaheim?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Anaheim research site will contact you about next steps.

Are clinical trials in Anaheim free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Anaheim studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 10 active trials in Anaheim are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated March 2, 2026 from ClinicalTrials.gov